EUVIMEDEUVIMED entdecken
Open Access

Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology

Yixiang Jiang iD, Yan Lin iD, Senthilkumar Krishnaswamy, Ruimin Pan iD, Qian Wu, Leslie A Sandusky-Beltran, Mengyu Liu, Min-Hao Kuo, Xiang-Peng Kong, Erin E Congdon, Einar M Sigurdsson iD

Science Advances · 2023

DOI: 10.1126/sciadv.adf3775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Yixiang Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Physiology, Neuroscience Institute, New York University Grossman School of Medicine, 435 East 30th Street, New York, N…. Hauptthemen laut MEDLINE: Single-Domain Antibodies, Synucleinopathies, Tauopathies. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intracellular deposition of α-synuclein and tau are hallmarks of synucleinopathies and tauopathies, respectively. Recently, several dye-based imaging probes with selectivity for tau aggregates have been developed, but suitable imaging biomarkers for synucleinopathies are still unavailable. Detection of both of these aggregates early in the disease process may allow for prophylactic therapies before functional impairments have manifested, highlighting the importance of developing specific imaging probes for these lesions. In contrast to the β sheet dyes, single-domain antibodies, found in camelids and a few other species, are highly specific, and their small size allows better brain entry and distribution than whole antibodies. Here, we have developed such imaging ligands via phage display libraries derived from llamas immunized with α-synuclein and tau preparations, respectively. These probes allow noninvasive and specific in vivo imaging of α-synuclein versus tau pathology in mice, with the brain signal correlating strongly with lesion burden. These small antibody derivatives have great potential for in vivo diagnosis of these diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Domain AntibodiesSynucleinopathiesTauopathiesMiceAnimalsalpha-Synucleintau ProteinsAntibodiesColoring Agents

Substanzen

alpha-SynucleinSingle-Domain Antibodiestau ProteinsAntibodiesColoring Agents

Autor:innen und Institutionen

  • Department of Neuroscience and Physiology, Neuroscience Institute, New York University Grossman School of Medicine, 435 East 30th Street, New York, NY 10016, USA.
  • Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, 550 First Avenue, New York, NY 10016, USA.
  • Department of Biochemistry and Molecular Biology, Michigan State University, 603 Wilson Road, East Lansing, MI 48824, USA.
  • Department of Psychiatry, New York University Grossman School of Medicine, 435 East 30th Street, New York, NY 10016, USA.

ORCID-Profile: Yixiang Jiang, Yan Lin, Ruimin Pan, Einar M Sigurdsson

Förderung

  • NCI NIH HHS
  • NIA NIH HHS
  • NINDS NIH HHS
  • NIBIB NIH HHS
  • NIH HHS

Zitieren

APA

Jiang, Y., Lin, Y., Krishnaswamy, S., Pan, R., Wu, Q., Sandusky-Beltran, L. A., Liu, M., Kuo, M. H., Kong, X. P., Congdon, E. E., & Sigurdsson, E. M. (2023). Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology. Science Advances. https://doi.org/10.1126/sciadv.adf3775

Vancouver

Jiang Y, Lin Y, Krishnaswamy S, Pan R, Wu Q, Sandusky-Beltran LA, et al. Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology. Science Advances. 2023. doi:10.1126/sciadv.adf3775

BibTeX
@article{Jiang2023,
  author = {Jiang, Yixiang and Lin, Yan and Krishnaswamy, Senthilkumar and Pan, Ruimin and Wu, Qian and Sandusky-Beltran, Leslie A and Liu, Mengyu and Kuo, Min-Hao and Kong, Xiang-Peng and Congdon, Erin E and Sigurdsson, Einar M},
  title = {Single-domain antibody–based noninvasive in vivo imaging of α-synuclein or tau pathology},
  journal = {Science Advances},
  year = {2023},
  doi = {10.1126/sciadv.adf3775}
}
Kostenlos starten →